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Abstract 27 
Background: Hepatocellular carcinoma (HCC), the most commonly occurring type of primary liver 28 
cancer, has been increasing in incidence worldwide. Vitamin D, acquired from sunlight exposure, diet, 29 
and dietary supplements, has been hypothesized to impact hepatocarcinogenesis. However, previous 30 
epidemiologic studies examining the associations between dietary and serum vitamin D reported mixed 31 
results. The purpose of this study was to examine the association between ambient ultraviolet (UV) 32 
radiation exposure and HCC risk in the U.S. 33 
Methods: The Surveillance, Epidemiology, and End Results (SEER) database provided information on 34 
HCC cases diagnosed between 2000 and 2014 from 16 population-based cancer registries across the U.S. 35 
Ambient UV exposure was estimated by linking the SEER county with a spatiotemporal UV exposure 36 
model using a geographic information system. Poisson regression with robust variance estimation was 37 
used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association 38 
between ambient UV exposure per interquartile range (IQR) increase (32.4 mW/m
2
) and HCC risk 39 
adjusting for age at diagnosis, sex, race, year of diagnosis, SEER registry, and county-level information 40 
on prevalence of health conditions, lifestyle, socioeconomic, and environmental factors. 41 
Results: Higher levels of ambient UV exposure were associated with statistically significant lower HCC 42 
risk (n = 56,245 cases; adjusted IRR per IQR increase: 0.83, 95% CI 0.77, 0.90; p<0.01). A statistically 43 
significant inverse association between ambient UV and HCC risk was observed among males (p for 44 
interaction = 0.01) and whites (p for interaction = 0.01). 45 
Conclusions: Higher ambient UV exposure was associated with a decreased risk of HCC in the U.S. UV 46 
exposure may be a potential modifiable risk factor for HCC that should be explored in future research.  47 
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Background 53 
Hepatocellular carcinoma (HCC) is the most commonly diagnosed histological type of primary liver 54 
cancer [1]. HCC accounts for between 85 and 90% of primary liver cancer cases [2]. Risk factors for 55 
HCC include chronic hepatitis B virus (HBV) infection and exposure to aflatoxin in parts of Asia and 56 
sub-Saharan Africa; chronic hepatitis C virus (HCV) infection is the predominant risk factor in Japan and 57 
Egypt [3]. In the U.S. and Europe, risk factors include chronic HCV infection, heavy alcohol 58 
consumption, obesity, diabetes, and metabolic syndrome [3]. Other risk factors include non-alcoholic 59 
fatty liver disease (and non-alcoholic steatohepatitis) and cigarette smoking; physical activity and coffee 60 
and tea consumption may be protective [1, 3-6]. Liver cancer incidence has been increasing across many 61 
areas around the world including the U.S. [7]. Approximately 40.5% of HCC cases in the U.S. remain 62 
unexplained by established risk factors such as HCV, HBV, alcohol consumption, diabetes, and obesity 63 
[8]. 64 
 Emerging evidence suggests that vitamin D may impact HCC risk. Vitamin D is a hormone 65 
acquired from sunlight exposure, diet, and dietary supplements that plays a major role in human health [9-66 
12]. Vitamin D from the skin and diet is metabolized in the liver to the major circulating form 25-67 
hydroxyvitamin D (25(OH)D) [11]. Experimental evidence has demonstrated that vitamin D exhibits 68 
many anti-hepatocarcinogenic activities including regulating bile acid levels through vitamin D receptor 69 
(VDR) [13-15]. However, the few epidemiologic studies that have examined the association between 70 
dietary and serum vitamin D and liver cancer risk while adjusting for liver cancer risk factors have shown 71 
mixed results – inverse, positive, and null associations [16-18]. 72 
 Vitamin D exposure can be assessed by its concentration in blood, amount consumed through diet 73 
and dietary supplements, and estimated from self-reported sun exposure and location-based ambient 74 
ultraviolet (UV) radiation exposure [19, 20]. The primary source of bioactive vitamin D in humans is 75 
production in skin upon solar UV-B (280-315 nm) exposure [10]; approximately 90% of circulating 76 
levels of vitamin D are attributed to sunlight exposure [19]. Previous epidemiologic studies have 77 
estimated long-term vitamin D status using satellite remote sensing images of UV combined with location 78 
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of residence (e.g., geocoded residential addresses) using geographic information systems (GIS), an 79 
exposure metric that has been predictive of cancer risk, showing protective associations for colon cancer 80 
and non-Hodgkin lymphoma [20-27]. While there is strong biological plausibility, to date, no 81 
epidemiologic studies have examined the possible association between personal or ambient UV exposure 82 
and the risk of developing HCC. The objective of this study was to evaluate the association between 83 
ambient UV exposure and HCC risk in the U.S. 84 
 85 
Methods 86 
Study population 87 
The U.S. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program 88 
collects individual-level information on cancer incidence, treatment, and survival from population-based 89 
cancer registries covering 28% of the U.S. population, including information on patient demographics, 90 
county at diagnosis, primary tumor site, and tumor morphology [28, 29]. The following registries were 91 
included in this analysis: (1) Atlanta (metropolitan); (2) Greater California; (3) Connecticut; (4) Detroit 92 
(metropolitan); (5) Greater Georgia; (6) Iowa; (7) Kentucky; (8) Los Angeles; (9) Louisiana (excluding 93 
July-December 2005 cases due to Hurricanes Katrina and Rita); (10) New Jersey; (11) New Mexico; (12) 94 
Rural Georgia; (13) San Francisco-Oakland; (14) San Jose-Monterey; (15) Seattle (Puget Sound); and 95 
(16) Utah. All counties located in the catchment areas captured by these 16 SEER registries were included 96 
in the analysis. The Alaska Natives, Arizona Indians, Cherokee Nation, and Hawaii registries were 97 
excluded as UV exposure data were not available outside of the contiguous U.S. and the Alaska Natives, 98 
Arizona Indians, and Cherokee Nation registries only collect information on American Indian/Alaska 99 
Native populations. To protect patient confidentiality, the SEER database does not include personal 100 
identifiers; this study was exempt from Institutional Review Board (IRB) review. 101 
 102 
 103 
 104 
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Case ascertainment 105 
HCC cases were defined using the following criteria: International Classification of Diseases for 106 
Oncology, Third Edition (ICD-O-3) topography code C22.0 (primary liver cancer) and ICD-O-3 histology 107 
codes 8170 to 8175 [30]; diagnostic confirmation (e.g., positive histology) excluding clinical diagnosis 108 
only [31]; sequence number of one primary only; diagnosis between 2000 and 2014; and not reported via 109 
autopsy or death certificate only [32]. As conducted in previous epidemiologic studies of UV and cancer 110 
in SEER, for each county, counts of HCC cases were stratified by age at diagnosis (≤44 years; 45-64; 111 
≥65); sex (male, female); race (white, black, Asian/Pacific Islander/American Indian/Alaska Native); year 112 
of diagnosis (2000-2007, 2008-2014); and SEER registry [33, 34]. 113 
 114 
Exposure assessment 115 
Ambient UV exposure was estimated for each county in the study area using a high spatiotemporal 116 
resolution UV model [35]. The model was created using area-to-point residual kriging to downscale 117 
National Aeronautics and Space Administration (NASA) erythemal UV satellite remote sensing images 118 
from the Total Ozone Mapping Spectrometer (TOMS) and Ozone Monitoring Instrument (OMI) satellite 119 
sensors. The UV model incorporated information on surface albedo, aerosol optical depth, cloud cover, 120 
dew point, elevation, ozone, surface incoming shortwave flux, sulfur dioxide, and latitude. The UV model 121 
predicts average July noon-time erythemal UV irradiance (mW/m
2
). Erythemal UV incorporates UV-A 122 
and UV-B wavelengths (involved in vitamin D production) to calculate a measure describing the relative 123 
effectiveness of UV to induce erythema on Caucasian skin; shorter UV-B wavelengths are weighted more 124 
in the calculation [36, 37]. July erythemal UV has been predictive of risk for skin, colorectal, and other 125 
cancers in previous epidemiologic studies [22, 24, 25, 38], and during July, erythemal UV is strongest, 126 
aerosols and other noise factors are less influential, and satellite-based measures are in better agreement 127 
with ground-based measures [25, 35]. The UV exposure model spans the contiguous U.S. The spatial 128 
resolution of the UV model is 1 x 1 km and the temporal resolution is yearly from 1980-2015. 129 
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Using U.S. county boundaries from 2000 [39], separately for each year from 1980-1999, the UV 130 
model was aggregated to the county level using GIS (i.e., UV raster cell centroids intersecting a given 131 
county were averaged to calculate a mean county UV value for each year). An annual county-level 132 
ambient UV average was calculated by averaging UV values from 1980-1999, as well as for different 133 
exposure windows in 1980, 1980-1985, 1980-1990, and 1980-1995. Annual average ambient UV values 134 
were linked with each county in the study area. The county at diagnosis was available for each case from 135 
SEER. All spatial analyses were conducted in ArcGIS (Esri, Redlands, CA) using the contiguous U.S. 136 
Albers equal area conic coordinate system (NAD83 datum; USGS version). 137 
 138 
Additional covariates 139 
The following information was ascertained from the SEER database: age at diagnosis, sex, race, year of 140 
diagnosis, SEER registry, and county at diagnosis for each case; and county-level educational attainment 141 
(percentage with a Bachelor’s degree or higher), poverty (percentage of individuals below the poverty 142 
level), percentage unemployed, median household income, and percentage foreign born (proxy for HBV 143 
prevalence as HBV is endemic in parts of Asia and Africa [1]) from the 2000 U.S. Census Bureau 144 
Summary Files, and U.S. Department of Agriculture Rural-Urban Continuum Codes (codes 1-7: urban; 8-145 
9: rural) [29, 40]. The following county-level data were acquired from the Institute for Health Metrics and 146 
Evaluation (IHME), which were created by applying small area models to data from the Behavioral Risk 147 
Factor Surveillance System and/or National Health and Nutrition Examination Survey: sex-specific age-148 
adjusted prevalence of any alcohol use in 2002 (≥one drink of any alcoholic beverage in past 30 days), 149 
heavy alcohol use in 2005 (average >1 drink per day for women or >2 drinks per day for men in past 30 150 
days), and binge drinking in 2002 (>4 drinks for women or >5 drinks for men on a single occasion at least 151 
once in past 30 days) [41, 42]; sex-specific age-adjusted prevalence of total diagnosed and undiagnosed 152 
diabetes in 2000 (proportion of adults aged ≥20 years who reported a previous diabetes diagnosis and/or 153 
have fasting plasma glucose ≥126 mg/dL and/or hemoglobin A1c ≥6.5%) [43, 44]; sex-specific age-154 
adjusted prevalence of any physical activity in 2001 (participation during the past month in any physical 155 
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activities or exercises such as running, calisthenics, golf, gardening, or walking for exercise outside of 156 
work) and obesity in 2001 (body mass index [BMI] ≥30 kg/m2) [45]; and sex-specific age-adjusted 157 
prevalence of total current smoking in 2000 (currently smoking cigarettes some days [daily or nondaily]) 158 
[46]. County-level age-adjusted drug poisoning-related mortality rates (ICD-10 underlying cause-of-death 159 
codes X40-X44 [unintentional], X60-X64 [suicide], X85 [homicide], or Y10-Y14 [undetermined intent]) 160 
were obtained from two-stage hierarchical models applied to the National Vital Statistics System multiple 161 
cause-of-death mortality files [47, 48]. Drug poisoning mortality was used as a proxy for HCV prevalence 162 
as a substantial proportion of drug poisoning deaths are attributed to injection drug use, which is the 163 
primary route of HCV transmission in the U.S. [49, 50]. County-level sex-specific percentages of the 164 
population employed in outdoor occupations (agriculture, forestry, fishing, hunting, or construction) were 165 
acquired from the 2000 U.S. Census Bureau Summary File 3 [20]. Particulate matter air pollution <2.5 166 
microns in diameter (PM2.5) is an International Agency for Research on Cancer (IARC) group 1 human 167 
carcinogen and has been shown to be associated with liver cancer risk in experimental and epidemiologic 168 
studies [51-55]. The U.S. Environmental Protection Agency (EPA) Air Quality System database annual 169 
summary file for ambient PM2.5 (µg/m
3
) in 2000 was downloaded. An interpolated raster surface of PM2.5 170 
values was created using inverse distance weighting in ArcGIS; interpolated PM2.5 raster cell centroids 171 
were intersected with county boundaries to calculate annual average ambient PM2.5 exposures for each 172 
county [56]. All county-level data were compiled using Federal Information Processing Standard (FIPS) 173 
codes. 174 
 175 
Statistical analysis 176 
Poisson regression with a robust variance estimator was used to calculate incidence rate ratios (IRRs) and 177 
95% confidence intervals (CIs) for the association between ambient UV exposure and the risk of 178 
developing HCC. UV exposure was examined continuously per interquartile range (IQR) increase (32.4 179 
mW/m
2
); the IQR was calculated across all 607 counties captured in the SEER registry catchment areas 180 
included in the analysis [33, 34]. Restricted cubic regression splines were used to test for deviations from 181 
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linearity. All models were adjusted for age at diagnosis, sex, race, year of diagnosis, and SEER Registry. 182 
The natural logarithm of the county population size acquired from the 2000 U.S. Census Bureau 183 
Summary File 3 was used as the offset in all models. Potential confounding was evaluated by adding each 184 
covariate or group of covariates to the model and noting its impact on the effect estimate for UV 185 
exposure. We explored effect modification by age, sex, race, year, any physical activity, obesity, heavy 186 
alcohol consumption, smoking, median household income, PM2.5, outdoor occupation, and urbanicity 187 
using stratified analyses; tests for interaction were performed by adding an interaction term to the model 188 
and using likelihood ratio tests to determine statistical significance. We performed sensitivity analyses 189 
stratifying by residential mobility using data on the percentage of the county population that stayed in the 190 
same house (no migration from 1995-2000) from the 2000 U.S. Census Bureau Summary File 1 provided 191 
in the SEER database (residing in counties where ≥51.9% [20th percentile of counties] of the population 192 
did not migrate vs. residing in counties where <51.9% did not migrate). We also performed sensitivity 193 
analyses stratifying by region of residence, which was determined by grouping each county and 194 
associated SEER registry into the following U.S. Census Bureau regions: Northeast: Connecticut, New 195 
Jersey; South: Atlanta (metropolitan), Greater Georgia, Rural Georgia, Kentucky, Louisiana; Midwest: 196 
Detroit (metropolitan), Iowa; and West: Greater California, Los Angeles, San Francisco-Oakland, San 197 
Jose-Monterey, New Mexico, Seattle (Puget Sound), Utah [57]; examining the effect of exposure lags of 198 
at least 20 years (1980), 15 years (1980-1985), 10 years (1980-1990), and 5 years (1980-1995); using 199 
Poisson models with a random intercept for county to examine potential county-level clustering; and 200 
using scaled Poisson models based on the Pearson and deviance methods to account for overdispersion 201 
[58]. All statistical analyses were conducted using SAS (SAS Institute, Cary, NC). 202 
 203 
Results 204 
There were 56,245 HCC cases diagnosed between 2000 and 2014 included in the analysis. HCC cases 205 
were on average 62.4 years of age at diagnosis, predominantly male (77.1%), white (68.5%), resided in 206 
the Western U.S. (61.5%), and were diagnosed between 2008 and 2014 (58.1%) (Table 1). The majority 207 
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of cases who were Asian or Pacific Islander (78.1%) were reported by the four California registries, and 208 
the majority of cases who were American Indian or Alaskan Native (79.2%) were reported by the Greater 209 
California, New Mexico, and Seattle registries. Using data from the underlying population from which 210 
HCC cases were sampled, HCC cases at the time of diagnosis resided in mostly urban counties (99.2%) 211 
where an average of 8.3% of the population engaged in heavy alcohol consumption, 23.9% smoked 212 
cigarettes, 25.7% were obese, and 11.4% had diabetes. Compared to all U.S. counties across the 213 
contiguous U.S. (Table 1), the counties in which the HCC cases resided were more likely to be urban 214 
areas characterized by higher average ambient UV levels, median household income, educational 215 
attainment, drug poisoning mortality, and prevalence of foreign-born individuals (Table 1). Figure 1 216 
shows annual average ambient UV exposure categorized by quintiles calculated using all 607 counties 217 
included in the study (each color classification corresponds to a quintile). From 1980-1999, annual 218 
average ambient UV levels ranged between 150.4 and 270.1 mW/m
2
. Higher UV levels were observed in 219 
the Western U.S. (counties in the California, New Mexico, Utah registries) and parts of Louisiana, while 220 
lower UV levels were observed in the Northeastern and Midwestern U.S. (Connecticut, Detroit, Iowa, 221 
Kentucky, New Jersey, and Seattle registries). 222 
 223 
[Table 1 here] 224 
 225 
  In basic models adjusting for age, sex, race, year, and SEER registry, higher ambient UV 226 
exposure was associated with lower HCC risk (IRR per IQR [32.4 mW/m
2
] increase: 0.90, 95% CI 0.81, 227 
0.99; p = 0.04) (Table 2). After further adjustment for county-level heavy alcohol consumption, smoking, 228 
obesity, diabetes, median household income, unemployment, urbanicity, and PM2.5, the inverse 229 
association between ambient UV exposure and HCC risk became stronger. An IQR increase in UV 230 
exposure was associated with a 17% lower risk of HCC (adjusted IRR 0.83, 95% CI 0.77, 0.90; p<0.01). 231 
Restricted cubic regression splines did not show evidence of deviations from linearity for the dose-232 
response (p=0.10). Model building is shown in Additional File 1, Table 1. 233 
10 
[Table 2 here] 234 
 235 
 There were statistically significant interactions between ambient UV exposure and sex (p for 236 
interaction = 0.01) and race (p = 0.01) (Table 3). Higher ambient UV exposure was significantly 237 
associated with a decreased risk of HCC among males (adjusted IRR 0.83, 95% CI 0.76, 0.91), but not 238 
among females; and among whites (adjusted IRR 0.88, 95% CI 0.80, 0.96) and Asians, Pacific Islanders, 239 
American Indians, and Alaskan Natives (adjusted IRR 0.67, 95% CI 0.48, 0.92), but not among blacks. 240 
However, the association between UV and HCC risk was consistently inverse across all strata defined by 241 
sex and race, although suggestive among females and blacks. The association between UV and HCC risk 242 
did not differ according to residential mobility (Table 3). Higher ambient UV exposure was statistically 243 
significantly associated with decreased HCC risk when examining exposure lags of (at least) 20 years 244 
(UV exposure estimated in 1980; p = 0.04), 15 years (1980-1985; p<0.01), 10 years (1980-1990; p<0.01), 245 
and 5 years (1980-1995; p<0.01) (Additional File 1, Table 2). Using Poisson regression with a random 246 
intercept for county and scaled Poisson models applying either the Pearson and deviance methods showed 247 
similar results. 248 
 249 
[Table 3 here] 250 
 251 
Discussion 252 
We observed a statistically significant inverse association between county-level ambient UV exposure 253 
and HCC risk in the SEER U.S. population after adjustment for individual-level age at diagnosis, sex, 254 
race, and year of diagnosis, SEER registry, and county-level information on health conditions, lifestyle, 255 
socioeconomic, and environmental factors. This association was modified by sex and race, where an 256 
inverse association was more apparent among male, whites, and Asians, Pacific Islanders, American 257 
Indians, and Alaskan Natives. To the best of our knowledge, this is the first epidemiologic study 258 
examining ambient UV exposure and HCC risk. 259 
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 HCC incidence has been dramatically increasing in the U.S. [59]. Liver cancer is a priority area 260 
for cancer prevention and control efforts worldwide [60]. HCC is often asymptomatic until diagnosed at a 261 
late stage and is associated with a low 5-year relative survival rate below 12% [61]. Yet more than one 262 
third of HCC cases in the U.S. are not explained by known risk factors such as chronic infection with 263 
HCV or HBV, alcohol consumption, diabetes, and obesity [8]. Recent evidence suggests that vitamin D is 264 
a modifiable factor that may influence the risk of developing HCC. Vitamin D suppresses hepatic stellate 265 
cell (HSC) proliferation [62], which when activated, facilitates excessive collagen accumulation – the 266 
hallmark of liver fibrosis. Activation of VDRs in HSCs strongly antagonizes TGF-β signaling, the most 267 
potent pro-fibrogenic pathway in the liver [63, 64]. Vitamin D also exhibits cytostatic and apoptotic 268 
effects in hepatic malignant cells that express VDR [65] and inhibits hepatic chromosomal aberrations 269 
and DNA breaks [66]. Several epidemiologic studies have examined vitamin D from diet or serum and 270 
primary liver cancer risk and have shown mixed results. In a prospective case-control study of 138 HCC 271 
cases nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, 272 
higher serum 25(OH)D levels were associated with a statistically significant decreased risk of HCC (IRR 273 
0.51, 95% CI 0.26, 0.99) after adjusting for age, sex, study center, date and time of blood collection, 274 
fasting status, smoking, BMI, alcohol consumption, and coffee consumption [17]. Vitamin D was 275 
assessed using a serum measurement at baseline occurring an average of 6 years before diagnosis. A 276 
second nested case-control study in EPIC (191 HCC cases) showed a statistically significant positive 277 
association between baseline dietary vitamin D intake (from dairy sources) and risk of HCC (HR 1.90, 278 
95% CI 1.19, 3.05) after adjusting for age, sex, study center, total energy intake, alcohol consumption, 279 
physical activity, BMI, smoking, and diabetes [16]. Higher intake of dairy foods is associated with higher 280 
levels of circulating insulin-like growth factor I (IGF-I), which have been hypothesized to promote 281 
hepatocarcinogenesis [67]. In both EPIC studies, similar results were observed after adjusting for 282 
HBV/HCV infection. A nested case-control study in the Linxian Nutrition Intervention Trials in China 283 
showed no association between baseline serum 25(OH)D and risk of primary liver cancer [18], although 284 
there was a statistically significant interaction between vitamin D and calcium. An inverse association 285 
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was observed among those with higher serum calcium concentrations; vitamin D signaling may be 286 
attenuated by low calcium levels [68]. HCC and other histological subtypes of liver cancer were included 287 
in this study, which might have masked the association due to a potential lack of impact of vitamin D on 288 
non-HCC liver cancer [69]. Further, the Linxian study population was characterized by a low and narrow 289 
range of vitamin D exposure, limiting generalizability and statistical power to detect an association. There 290 
was no strong evidence of confounding by the factors evaluated in these studies for the association 291 
between vitamin D and liver cancer [16-18]. Although these studies provide inconsistent results regarding 292 
the relationship between vitamin D and liver cancer risk in Europe and China, this present study provides 293 
evidence in support of sunlight exposure, the major source of vitamin D from UV-B, and HCC risk. For a 294 
given individual, the chronic and constant exposure to UV-B may provide a steady source of vitamin D, 295 
which may complement the measurement of serum vitamin D reflecting acute exposures in previous 296 
studies [17-19]. 297 
 We examined the association between ambient UV exposure and HCC risk using information 298 
from population-based cancer registries across the U.S. We observed a statistically significant dose-299 
response relationship with increasing ambient UV exposure and decreasing HCC risk. Results were 300 
adjusted for many established HCC risk factors such as individual-level age, sex, and race, as well as 301 
county-level information on heavy alcohol consumption, smoking, obesity, diabetes, and socioeconomic 302 
and environmental factors. We adjusted for county-level ambient PM2.5 air pollution, an environmental 303 
exposure that has been shown to potentially increase HCC risk [51-55]. In our analysis, PM2.5 was the 304 
strongest confounder in the relationship between UV and HCC risk; its adjustment strengthened the 305 
observed inverse association. It is known that UV and PM2.5 are negatively associated with each other, 306 
where PM2.5 can absorb and/or scatter UV, thus impacting the amount of UV reaching the Earth’s surface 307 
[70]. Location-based ambient UV exposure was objectively estimated through linking the SEER county 308 
with a high spatial- and temporal-resolution UV model using GIS. Average annual July erythemal UV 309 
was estimated, which has been used in previous cancer epidemiologic studies [24, 25] and is relevant to 310 
studying chronic diseases in considering long-term average exposure. Although the mechanisms 311 
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underlying the potential effect of vitamin D on hepatocarcinogenesis may differ from those of other 312 
known risk factors, there has been an observed 20-year latency period for some liver cancer risk factors 313 
[71]. We explored potential latency periods by examining exposure lags and observed significant inverse 314 
associations between ambient UV exposure and HCC risk when estimating exposure at least 5, 10, 15, 315 
and 20 years before diagnosis. 316 
Ambient UV exposure measures have been predictive of cancer risk, for example demonstrating 317 
adverse associations with skin cancer risk where the underlying mechanism is DNA damage as well as 318 
inverse associations with colon and other cancers where the mechanism is related to vitamin D protection  319 
[20-27, 72]. Although ambient UV is an indirect measure, UV-B sunlight exposure is considered an 320 
important predictor of vitamin D status in the population [73]. Sunlight exposure, in addition to diet, are 321 
considered to be reasonable measures for long-term vitamin D status [19]. Further, sunlight exposure 322 
accounts for approximately 90% of circulating levels of vitamin D [19]. Baseline serum 25(OH)D reflects 323 
short-term vitamin D status rather than long-term vitamin D exposure, the latter being more relevant to 324 
carcinogenesis. Although an intraclass correlation coefficient (ICC) of 0.72 has been observed for plasma 325 
25(OH)D levels measured over 2-3 years, the ICC decreased over time to 0.50 (95% CI 0.43, 0.57) over 326 
10-11 years, demonstrating increasing within-person variability [74]. Other studies have reported ICCs 327 
ranging between 0.42 and 0.72 over 2-14 years [75-78]. Serum measurements are also subject to intra-328 
individual variation related to residence in high UV-B areas and changes in lifestyle practices (e.g., 329 
sunscreen use) over time [19]. Ambient UV represents an informative measure for studies seeking to 330 
examine the role of vitamin D in human health outcomes, and can be used in combination with direct 331 
assessments of vitamin D, such as using serum and diet, to comprehensively capture vitamin D status.  332 
There were statistically significant interactions between ambient UV exposure and sex and race. 333 
A statistically significant inverse association was observed among males, while no association was 334 
observed among females. These results may be explained by the smaller sample size of females and/or 335 
vitamin D deficiency being more common among females compared to males, partially attributed to sex-336 
specific differences in outdoor activities, clothing for skin coverage, seeking shade, and sunscreen use 337 
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[79, 80]. Results were similar after adjustment for sex-specific county-level outdoor occupation. An 338 
inverse association was observed among whites and Asians, Pacific Islanders, American Indians, and 339 
Alaskan Natives but not blacks, consistent with how darker skin, associated with increased melanin, 340 
absorbs between 50 and 75% of UV, thus reducing vitamin D production in the skin and manifesting in 341 
higher rates of vitamin D deficiency among non-whites [81-83]. However, results among blacks were 342 
suggestively inverse and the sample sizes for blacks as well as Asians, Pacific Islanders, American 343 
Indians, and Alaskan Natives were smaller compared to whites. Racial and ethnic differences in dietary 344 
intake may have also contributed to these results [84]. Differential patterns of residential mobility may 345 
also exist according to sex and race. 346 
 Limitations of this study include absence of information on personal UV exposure and potential 347 
exposure misclassification associated with using the county of residence (at diagnosis among cases).  348 
Study results may be subject to the ecological fallacy, where the association between area-level ambient 349 
UV, as a moderate proxy for vitamin D status, and HCC may not reflect the individual-level association 350 
between vitamin D and HCC. For example, although previous studies have demonstrated an inverse 351 
association between area-level UV and breast cancer incidence, individual-level studies of personal 352 
sunlight exposure and serum vitamin D have not been able to consistently replicate these findings [85, 353 
86]. However, both ecological and individual-level studies examining ambient UV and serum vitamin D 354 
have demonstrated inverse associations with colorectal cancer risk [20, 87, 88]. Additional studies 355 
examining individual-level exposure of vitamin D and HCC risk are needed. We used a high-resolution 356 
spatiotemporal UV model validated against ground truth UV monitoring data [35] to estimate exposure 357 
and exposure was assessed similarly across all counties in the study. Further, counties have been used in 358 
previous epidemiologic studies as geographic variables capturing activity space, or the local areas within 359 
which people move or travel during the course of their daily activities interacting with their environment 360 
[89, 90]. We estimated UV exposure beginning in 1980 and assumed that cases did not move over the 361 
study time period. Although we did not have information on residential history, cases lived in counties 362 
where a large proportion of individuals did not migrate; an average of 58% of county residents stayed in 363 
15 
the same home between 1995 and 2000 (10
th
 percentile was 48%). Further, results were similar after 364 
stratifying by county residential mobility. Residual confounding due to lack of information on individual-365 
level risk factors for HCC, including alcohol consumption and obesity, is a limitation. However, we were 366 
able to adjust for county-level information on known and suspected HCC risk factors, including heavy 367 
alcohol consumption, smoking, obesity, diabetes, socioeconomic factors, urbanicity, and PM2.5. We also 368 
evaluated potential confounding by county-level outdoor occupation (affects UV exposure levels), drug 369 
poisoning mortality (proxy for HCV prevalence), and percentage of foreign-born individuals (proxy for 370 
HBV prevalence), none of which substantially changed the effect estimate for the association between 371 
ambient UV and HCC. In particular, although the percentage of foreign-born individuals was higher in 372 
counties in which HCC cases resided compared to all counties in the U.S., there was a weak positive 373 
association between percentage of foreign-born individuals and county-level ambient UV levels. Further, 374 
HBV and HCV, the latter being the major risk factor for liver cancer in the U.S., have not been associated 375 
with vitamin D in several previous studies, suggesting that HBV and HCV are not likely to be strong 376 
confounders of the association [16-18]. Obesity is the major risk factor for non-HBV/HCV-related HCC 377 
in the U.S. Lower vitamin D levels are associated with obesity [91], however it is unclear if ambient UV 378 
is associated with obesity, although obesity prevalence is higher in the Southern U.S. where UV levels are 379 
high [92]. We adjusted for county-level obesity, although residual confounding remains an issue. We also 380 
lacked information on individual-level sun exposure and protection, including sun reaction, sunscreen 381 
use, tanning booth use, and time spent outdoors, although we did consider sex-specific county-level 382 
percentage of the population employed in outdoor occupations in our analysis (results did not change after 383 
adjustment). We did not have information on dietary and supplemental vitamin D intake. Strengths of our 384 
study include the large sample size of HCC cases and objective location-based exposure assessment 385 
utilizing a high-resolution spatially- and temporally-varying UV model created using information 386 
regarding known predictors of UV including ozone, aerosol optical depth, and cloud cover. The counties 387 
included in the study area span the contiguous U.S. and are characterized by a wide range of UV values. 388 
Using information from various objective data sources including SEER, U.S. Census Bureau, IHME, and 389 
16 
EPA, we were able to evaluate potential confounding and effect modification by many different variables 390 
including age, sex, and race. 391 
 392 
Conclusions 393 
Higher ambient UV exposure was associated with a statistically significant reduced risk of HCC in the 394 
U.S. The incidence rate of HCC has increased in many parts of the world including the U.S. UV 395 
exposure, a major source of vitamin D production, may be a potential modifiable risk factor for HCC. 396 
Additional studies examining the association between individual-level measures of vitamin D in blood or 397 
from other sources, including diet and dietary supplements, and HCC risk should be conducted. 398 
 399 
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; CI, confidence interval; EPA, 400 
Environmental Protection Agency; EPIC, European Prospective Investigation into Cancer and Nutrition; 401 
FIPS, Federal Information Processing Standard; GIS, geographic information system; HBV, hepatitis B 402 
virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HSC, hepatic stellate cell; IARC, 403 
International Agency for Research on Cancer; ICC, intraclass correlation coefficient; ICD-10, 404 
International Classification of Diseases, Tenth Revision; ICD-O-3, International Classification of 405 
Diseases for Oncology, Third Edition; IGF-I, insulin-like growth factor I; IHME, Institute for Health 406 
Metrics and Evaluation; IQR, interquartile range; IRB, Institutional Review Board; IRR, incidence rate 407 
ratio; NAD83, North American Datum of 1983; NASA, National Aeronautics and Space Administration; 408 
OMI, Ozone Monitoring Instrument; PM2.5, particulate matter <2.5 microns in diameter; SD, standard 409 
deviation; SEER, Surveillance, Epidemiology, and End Results; TGF-β, transforming growth factor beta; 410 
TOMS, Total Ozone Mapping Spectrometer; U.S., United States; USGS, U.S. Geological Survey; UV, 411 
ultraviolet radiation; UV-A, ultraviolet A radiation; UV-B, ultraviolet B radiation; VDR, vitamin D 412 
receptor. 413 
 414 
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Figure titles and legends 674 
Figure 1 Ambient UV exposure from 1980-1999 by quintiles across 607 counties (16 SEER registries).675 
24 
Table 1 Characteristics of HCC cases and comparison of counties where cases lived vs. all U.S. counties 676 
 677 
 Cases (n = 56,245) U.S. counties
a
 
Age at diagnosis (mean ± SD) 62.4 ± 11.6  
Sex (n[%])   
Male  43,357 (77.1)  
Female 12,888 (22.9)  
Race (n[%])   
White 38,546 (68.5)  
Black 7,737 (13.8)  
Asian or Pacific Islander 9,305 (16.5)  
American Indian or Alaskan Native 657 (1.2)  
Region of residence at diagnosis   
Northeast 7,596 (13.5)  
South 9,995 (17.8)  
Midwest 4,084 (7.3)  
West 34,570 (61.5)  
Year of diagnosis (n[%])   
2000-2007 23,589 (41.9)  
2008-2014 32,656 (58.1)  
Average UV from 1980-1999 (mW/m
2
) (mean ± SD)
b
 214.4 ± 36.1 193.1 ± 24.2 
Heavy alcohol consumption (mean ± SD)
b
 8.3 ± 2.2 6.4 ± 2.1 
Smoking status (mean ± SD)
b
 23.9 ± 4.8 26.7 ± 3.6 
Any physical activity (mean ± SD)
b,c
 76.9 ± 5.8 71.7 ± 6.1 
Obesity (mean ± SD)
b,c
 25.7 ± 4.1 30.0 ± 3.9 
Diabetes (mean ± SD)
b
 11.4 ± 1.7 10.9 ± 1.9 
Median household income ($10,000) (mean ± SD)
b
 47.1 ± 11.1 35.3 ± 8.8 
Bachelor’s degree or higher (mean ± SD)b 26.1 ± 9.2  16.5 ± 7.8  
Unemployed (mean ± SD)
b
 6.5 ± 2.3 5.8 ± 2.7 
Urbanicity (n[%])
b
   
Rural 460 (0.8)  21.1 
Urban 55,785 (99.2) 78.8  
PM2.5 (ug/m
3
) (mean ± SD)
b
 14.6 ± 3.1 12.6 ± 3.2 
Occupation in agriculture, forestry, fishing, hunting, or construction (mean ± SD)
b
 13.8 ± 8.4 13.9 ± 3.8 
Drug poisoning mortality rate (per 100,000) (n[%])
b
   
0-2  617 (1.1) 23.1 
25 
2.1-10 50,429 (89.7) 70.4 
≥10.1 5,199 (9.2) 6.5 
Foreign born (mean ± SD)
b
 17.9 ± 12.1 3.4 ± 7.8 
 678 
Abbreviations: HCC, hepatocellular carcinoma; PM2.5, particulate matter <2.5 microns; SD, standard deviation; SEER, Surveillance, 679 
Epidemiology, and End Results; UV, ultraviolet radiation. 680 
a
Characteristics of the 3,108 counties across the contiguous U.S. (including Washington D.C.). 681 
b
County-level information based on the county at diagnosis for cases from SEER. 682 
c
Sex-specific any physical activity and obesity prevalence rates were averaged to estimate a total prevalence. 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
 698 
 699 
 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
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Table 2 Association between ambient UV and HCC incidence (SEER 2000-2014) 711 
 712 
UV exposure Cases (n) 
Basic
a
 
IRR (95% CI) p 
Fully adjusted
b
 
IRR (95% CI) p 
UV (per IQR increase)
c
 56,245 0.90 (0.81, 0.99) 0.04 0.83 (0.77, 0.90) <0.01 
 713 
Abbreviations: CI, confidence interval; HCC, hepatocellular carcinoma; IQR, interquartile range; IRR, incidence rate ratio; SEER, Surveillance, 714 
Epidemiology, and End Results; UV, ultraviolet radiation. 715 
a
Adjusted for age at diagnosis, sex, race, year of diagnosis, and SEER registry. 716 
b
Additionally adjusted for the following county-level variables: prevalence of heavy alcohol consumption, smoking, obesity, diabetes; median 717 
household income; percentage unemployed; urbanicity; PM2.5. 718 
c
IQR corresponds to 32.4 mW/m
2
. 719 
 720 
 721 
 722 
 723 
 724 
 725 
 726 
 727 
 728 
 729 
 730 
 731 
 732 
 733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
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Table 3 Association between ambient UV and HCC incidence stratified by sex, race, and residential mobility  744 
 745 
UV exposure (per IQR increase)
a
 Cases (n) 
Fully adjusted
b
 
IRR (95% CI) p int. 
Sex   0.01 
Male 43,357 0.83 (0.76, 0.91)  
Female 12,888 0.95 (0.85, 1.07)  
Race   0.01 
White 38,546 0.88 (0.80, 0.96)  
Black 7,737 0.85 (0.57, 1.26)  
Asian, Pacific Islander, American Indian, Alaskan Native 9,962 0.67 (0.48, 0.92)  
Residential mobility
c
   0.86 
Non-movers 31,039 0.78 (0.69, 0.88)  
Movers 25,206 0.88 (0.79, 0.99)  
 746 
Abbreviations: CI, confidence interval; HCC, hepatocellular carcinoma; IQR, interquartile range; IRR, incidence rate ratio; UV, ultraviolet 747 
radiation. 748 
a
IQR corresponds to 32.4 mW/m
2
. 749 
b
Adjusted for age at diagnosis, sex, race, year of diagnosis, SEER registry, and the following county-level variables: prevalence of heavy alcohol 750 
consumption, smoking, obesity, diabetes; median household income; percentage unemployed; urbanicity; PM2.5. 751 
c
Non-movers were defined as those who resided in a county where ≥51.9% (20th percentile) of the population stayed in the same home (no 752 
migration). Movers resided in a county where <51.9% of the population stayed in the same home. 753 
  
Figure 1 Ambient UV exposure from 1980-1999 by quintiles across 607 counties (16 SEER registries) 
Additional File 1 Modeling the association between ambient UV and HCC incidence and analyses using exposure lags of 5-20 years 
 
 
 
Table 1 Modeling the association between ambient UV and HCC incidence (SEER 2000-2014) 
 
Model
a
 Cases (n) IRR (95% CI)
b
 p 
Age at diagnosis, sex, race, year of diagnosis, SEER registry 56,245 0.90 (0.81, 0.99) 0.04 
Heavy alcohol consumption, smoking 56,245 0.93 (0.83, 1.03) 0.16 
Obesity, diabetes 56,245 0.90 (0.82, 0.99) 0.04 
Median household income, percentage unemployed, urbanicity 56,245 0.88 (0.82, 0.94) <0.01 
PM2.5 56,245 0.83 (0.77, 0.90) <0.01 
 
Abbreviations: CI, confidence interval; HCC, hepatocellular carcinoma; IQR, interquartile range; IRR, incidence rate ratio; SEER, Surveillance, 
Epidemiology, and End Results; UV, ultraviolet radiation. 
a
Each model additionally adjusts for the variables in the previous models. 
b
Continuous UV exposure per IQR increase; IQR corresponds to 32.4 mW/m
2
. 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Association between ambient UV and HCC incidence (SEER 2000-2014) across different exposure lags 
 
UV exposure (per IQR increase)
a
 Cases (n) 
Basic
b
 
IRR (95% CI) p 
Fully adjusted
c
 
IRR (95% CI) p 
Exposure time period: 1980 56,245 0.97 (0.91, 1.03) 0.30 0.95 (0.91, 0.99) 0.04 
Exposure time period: 1980-1985 56,245 0.93 (0.87, 1.00) 0.07 0.90 (0.85, 0.95) <0.01 
Exposure time period: 1980-1990 56,245 0.92 (0.85, 1.00) 0.07 0.88 (0.83, 0.93) <0.01 
Exposure time period: 1980-1995 56,245 0.90 (0.82, 0.99) 0.04 0.84 (0.78, 0.91) <0.01 
 
Abbreviations: CI, confidence interval; HCC, hepatocellular carcinoma; IQR, interquartile range; IRR, incidence rate ratio; SEER, Surveillance, 
Epidemiology, and End Results; UV, ultraviolet radiation. 
a
IQR corresponds to 23.1 mW/m
2
 for 1980, 25.1 mW/m
2
 for 1980-1985, 25.3 mW/m
2
 for 1980-1990, and 31.4 mW/m
2
 for 1980-1995. 
b
Adjusted for age at diagnosis, sex, race, year of diagnosis, and SEER registry. 
c
Additionally adjusted for the following county-level variables: prevalence of heavy alcohol consumption, smoking, obesity, diabetes; median 
household income; percentage unemployed; urbanicity; PM2.5. 
